0001104659-21-148674.txt : 20211210 0001104659-21-148674.hdr.sgml : 20211210 20211210170750 ACCESSION NUMBER: 0001104659-21-148674 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211208 FILED AS OF DATE: 20211210 DATE AS OF CHANGE: 20211210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rolph Timothy CENTRAL INDEX KEY: 0001779479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38944 FILM NUMBER: 211486153 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY, 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akero Therapeutics, Inc. CENTRAL INDEX KEY: 0001744659 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-487-6488 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm2135157-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-08 0 0001744659 Akero Therapeutics, Inc. AKRO 0001779479 Rolph Timothy C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 21.1 2021-12-08 4 A 0 87221 0 A 2031-12-07 Common Stock 87221 87221 D This option shall vest and become exercisable in 48 equal monthly installments commencing on December 8, 2021. /s/ Jonathan Young, Attorney in Fact 2021-12-10